Conditions: Dyslipidemias
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 165
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if 12 weeks of treatment with LY2484595 administered as a monotherapy will significantly increase high-density lipoprotein cholesterol (HDL-C) and decrease low-density lipoprotein cholesterol (LDL-C) in Japanese participants.

Detailed description:

Arms:
arm 1: Administered orally once daily for 12 weeks arm 2: Administered orally once daily for 12 weeks arm 3: Administered orally once daily for 12 weeks arm 4: Administered orally once daily for 12 weeks arm 5: Administered orally once daily for 12 weeks arm 6: Administered orally once daily for 12 weeks

Interventions: intervention 1: LY2484595 intervention 2: Placebo intervention 3: Atorvastatin
Intervention descriptions: intervention 1: Administered orally intervention 2: Administered orally intervention 3: Administered orally

Protocol document: